Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 27,617 | 26,240 | 24,293 | 21,592 | 18,567 |
| Operating Income | -27,617 | -26,240 | -24,293 | -21,592 | -18,567 |
| Other Income | 38 | 38 | 32 | 116 | 191 |
| Pre-tax Income | -27,579 | -26,202 | -24,261 | -21,476 | -18,376 |
| Income Tax | 160 | 42 | 51 | 36 | 75 |
| Net Income Continuous | -27,739 | -26,244 | -24,312 | -21,512 | -18,451 |
| Net Income | $-27,739 | $-26,244 | $-24,312 | $-21,512 | $-18,451 |
| EPS Basic Total Ops | -0.72 | -0.69 | -0.64 | -0.58 | -0.52 |
| EPS Basic Continuous Ops | -0.73 | -0.69 | -0.64 | -0.58 | -0.52 |
| EPS Diluted Total Ops | -0.72 | -0.69 | -0.64 | -0.58 | -0.52 |
| EPS Diluted Continuous Ops | -0.73 | -0.69 | -0.64 | -0.58 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -0.69 | -0.64 | N/A | N/A |
| EBITDA(a) | $-26,766 | $-25,467 | $-23,603 | $-21,079 | $-18,089 |